Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 3/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PLAU | P00749 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26123972 | 0.86 | PKM (0.37) | SMN1; SMN2PKMLMNAALDH1A1 | |
| SCHEMBL3264887 | 0.83 | RXFP1 (0.43) | RXFP1SMN1; SMN2F2PLAUELANE | |
| SCHEMBL23248467 | 0.71 | RXFP1 (0.36) | RXFP1SMN1; SMN2F2PLAUELANE | |
| SCHEMBL2518415 | 0.70 | PKM (0.40) | SMN1; SMN2PKMLMNAALDH1A1 | |
| SCHEMBL26120935 | 0.67 | POLB (0.40) | SMN1; SMN2PKMLMNAALDH1A1 | |
| SCHEMBL574383 | 0.67 | RXFP1 (0.49) | RXFP1SMN1; SMN2F2PLAUELANE | |
| SCHEMBL18520107 | 0.66 | MAPT (0.45) | RXFP1HSP90AA1LMNAALDH1A1 | |
| SCHEMBL15329966 | 0.64 | RXFP1 (0.41) | RXFP1SMN1; SMN2F2PLAUELANE | |
| SCHEMBL27275347 | 0.64 | RXFP1 (0.44) | RXFP1SMN1; SMN2F2PLAUELANE | |
| SCHEMBL23248575 | 0.64 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021075476-A1 | HETEROCYCLIC COMPOUND | 武田薬品工業株式会社 | 2021-04-22 | — | — | WO | disclosed |